Evidence map›Paper›PMID 37778940›Full record

ArticleTrends in pharmacological sciences2023

Structural asymmetry in FGF23 signaling.

Shih-Hsien Liu, Zhousheng Xiao, Jeremy C Smith, L Darryl Quarles

Abstract read
In one paragraph

Article in Trends in pharmacological sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Shih-Hsien LiuUT/ORNL Center for Molecular Biophysics, Oak Ridge National Laboratory, Oak Ridge, TN 37831, USA; Department of Biochemistry and Cellular and Molecular Biology, University of Tennessee, Knoxville, TN 37996, USA.
Zhousheng XiaoDepartment of Medicine, College of Medicine, University of Tennessee Health Science Center, Memphis, TN 38163, USA.
Jeremy C SmithUT/ORNL Center for Molecular Biophysics, Oak Ridge National Laboratory, Oak Ridge, TN 37831, USA; Department of Biochemistry and Cellular and Molecular Biology, University of Tennessee, Knoxville, TN 37996, USA.
L Darryl QuarlesDepartment of Medicine, College of Medicine, University of Tennessee Health Science Center, Memphis, TN 38163, USA. Electronic address: dquarles@uthsc.edu.

Funding

Skeletal Functions of Polycystins and TAZR01AR071930 · NIAMS · UNIVERSITY OF TENNESSEE HEALTH SCI CTR · PI XIAO, ZHOUSHENG · 2018 to 2022
$1.6M
Optimization of Novel Small Molecules to Antagonize FGF-23R01DK121132 · NIDDK · UNIVERSITY OF TENNESSEE HEALTH SCI CTR · PI XIAO, ZHOUSHENG · 2019 to 2023
$1.5M
NIAMS NIH HHS R01 AR071930NIDDK NIH HHS R01 DK121132
6 · The paper itself

Abstract

Chen et al. have derived cryogenic electron microscopy (cryo-EM) structures of signaling complexes of the endocrine hormone fibroblast growth factor 23 (FGF23) with fibroblast growth factor receptor (FGFR), α-Klotho, and heparin sulfate. These structures are asymmetric, leading to questions concerning in vivo function, and will facilitate structure-based drug design to modulate FGF23 signaling.

Indexed as

Fibroblast Growth FactorsKlotho ProteinsGlucuronidaseHumansReceptors, Fibroblast Growth FactorSignal TransductionFibroblast Growth FactorsGlucuronidaseKlotho ProteinsReceptors, Fibroblast Growth Factordrug discoveryFGF23FGFRFGF signalingα-Klotho

Identifiers

PMID37778940
PMCPMC11675616

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.